ArticleMolecular cancer2023

SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis.

Abdel Jelil Njouendou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.